这篇文章不错，转发给_老虎社区_美港股上老虎

Am Hogan
2022-12-01

这篇文章不错，转发给大家看看

港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股冠脉支架接续集采均价拟上浮约10%

据国家医保局消息，本次国家组织冠脉支架接续采购共有10家企业的14个产品获拟中选资格。值得关注的是，此次接续采购中选支架平均价格770元左右，相较于首次支架集采结果，续约产品中标价格普遍上涨，中标均价上浮约10%。续约产品的价格上涨引发业界诸多猜测，市场憧憬未来集采将开始涨价。

港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股冠脉支架接续集采均价拟上浮约10%

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":620400079,"tweetId":"620400079","gmtCreate":1669879961791,"gmtModify":1669879963727,"author":{"id":3530145821635645,"idStr":"3530145821635645","authorId":3530145821635645,"authorIdStr":"3530145821635645","name":"Am Hogan","avatar":"https://static.tigerbbs.com/e08ad1fc5386d91809c3851edf5175fb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>\n 这篇文章不错，转发给大家看看</body></html>","htmlText":"<html><head></head><body>\n 这篇文章不错，转发给大家看看</body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/620400079","repostId":2288626839,"repostType":2,"repost":{"id":"2288626839","kind":"news","pubTimestamp":1669879216,"share":"https://www.laohu8.com/m/news/2288626839?lang=&edition=full","pubTime":"2022-12-01 15:20","market":"us","language":"zh","title":"港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股 冠脉支架接续集采均价拟上浮约10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2288626839","media":"智通财经","summary":"据国家医保局消息，本次国家组织冠脉支架接续采购共有10家企业的14个产品获拟中选资格。值得关注的是，此次接续采购中选支架平均价格770元左右，相较于首次支架集采结果，续约产品中标价格普遍上涨，中标均价上浮约10%。续约产品的价格上涨引发业界诸多猜测，市场憧憬未来集采将开始涨价。","content":"<html><body><p>智通财经APP获悉，医疗器械股普涨，截至发稿，心通医疗(02160)涨7.54%，报2.71港元；<a href=\"https://laohu8.com/S/02500\">启明医疗-B</a>(02500)涨6.42%，报13.6港元；<a href=\"https://laohu8.com/S/01789\">爱康医疗</a>(01789)涨4.68%，报8.05港元；<a href=\"https://laohu8.com/S/00853\">微创医疗</a>(00853)涨4.49%，报19.1港元。</p><p>11月29日，国家组织冠脉支架集采协议期满后接续采购在江苏常州开标，产生拟中选结果。据国家医保局消息，本次国家组织冠脉支架接续采购共有10家企业的14个产品获拟中选资格。值得关注的是，此次接续采购中选支架平均价格770元左右，相较于首次支架集采结果，续约产品中标价格普遍上涨，中标均价上浮约10%。续约产品的价格上涨引发业界诸多猜测，市场憧憬未来集采将开始涨价。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股 冠脉支架接续集采均价拟上浮约10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股 冠脉支架接续集采均价拟上浮约10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-12-01 15:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/840480.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，医疗器械股普涨，截至发稿，心通医疗(02160)涨7.54%，报2.71港元；启明医疗-B(02500)涨6.42%，报13.6港元；爱康医疗(01789)涨4.68%，报8.05港元；微创医疗(00853)涨4.49%，报19.1港元。11月29日，国家组织冠脉支架集采协议期满后接续采购在江苏常州开标，产生拟中选结果。据国家医保局消息，本次国家组织冠脉支架接续采购共有10家...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/840480.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"159883":"医疗器械","BK1100":"医疗保健设备","09996":"沛嘉医疗-B","02160":"心通医疗-B","02500":"启明医疗-B","BK1583":"高瓴概念","BK1222":"医疗保健用品","09997":"康基医疗","00853":"微创医疗","01789":"爱康医疗","BK1589":"北水核心资产","BK1585":"昨日强势股","BK1574":"生物医药B类股"},"source_url":"http://www.zhitongcaijing.com/content/detail/840480.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2288626839","content_text":"智通财经APP获悉，医疗器械股普涨，截至发稿，心通医疗(02160)涨7.54%，报2.71港元；启明医疗-B(02500)涨6.42%，报13.6港元；爱康医疗(01789)涨4.68%，报8.05港元；微创医疗(00853)涨4.49%，报19.1港元。11月29日，国家组织冠脉支架集采协议期满后接续采购在江苏常州开标，产生拟中选结果。据国家医保局消息，本次国家组织冠脉支架接续采购共有10家企业的14个产品获拟中选资格。值得关注的是，此次接续采购中选支架平均价格770元左右，相较于首次支架集采结果，续约产品中标价格普遍上涨，中标均价上浮约10%。续约产品的价格上涨引发业界诸多猜测，市场憧憬未来集采将开始涨价。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1177,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股 冠脉支架接续集采均价拟上浮约10%

评论

热议股票

港股异动 | 心通医疗-B(02160)涨超7%领涨医疗器械股冠脉支架接续集采均价拟上浮约10%